Article Sidebar
Published:
Jul 20, 2021Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Effect of dexmedetomidine on blood T cell proliferation, T cell subsets and phagocytic function of alveolar macrophages in young rats subjected to splenectomy
Abstract
Purpose: To study the effect of dexmedetomidine on blood T cell proliferation, T cell subsets and phagocytosis of alveolar macrophages in young rats undergoing splenectomy.
Methods: Fifty-four healthy male rats were used for the establishment of an animal model of splenectomy. The young rats were randomly assigned to control, model (untreated) and medication groups, each with 18 rats. The rats in the control and model groups were given physiological saline at a dose of 10 ml/kg, while those in the treatment group were injected with dexmedetomidine at a dose of 50 µg/kg. All treatments were given intraperitoneally (i.p.). T cell proliferation, T cell subset level, phagocytic index and degree of phagocytosis of alveolar macrophages were compared among the rat groups.
Results: Relative to control, CD4+, CD8+ and CD4+/CD8+ levels in model and medication groups decreased significantly (p < 0.05). CD4+ and CD8+ levels were lower in the medication group than in model group. Phagocytic index and degree of phagocytosis of alveolar macrophages in model and medication groups were significantly lower than those in the control group, while phagocytic index and degree of phagocytosis of alveolar macrophages in the medication group of rats were smaller than those in model rats (p < 0.05).
Conclusion: Dexmedetomidine significantly reduces immune function in splenectomy rats. However, it should be used with caution in patients with splenectomy.
